Paper33398166
Targeting the mitochondria to block tumour growth.
Crunkhorn S. Nat Rev Drug Discov, 2021. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Targeting the mitochondria to block tumour growth. Papers, record 33398166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33398166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA, Mitochondrial | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Mitochondria |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 33328633 | Small-molecule inhibitors of human mitochondrial DNA transcription. | https://conductscience.org/library/papers/33328633 |
Source PubMed
References1
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|---|
| 1 | 33328633 | Small-molecule inhibitors of human mitochondrial DNA transcription. | Nature | 2020 | https://conductscience.org/library/papers/33328633 |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40249372 | Update on the correlation between mitochondrial function and osteonecrosis of the femoral head osteocytes. | Redox Rep | 2025 | https://conductscience.org/library/papers/40249372 | PubMed |
| 38654380 | Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer. | J Transl Med | 2024 | https://conductscience.org/library/papers/38654380 | PubMed |
| 37736880 | OXPHOS-targeting drugs in oncology: new perspectives. | Expert Opin Ther Targets | 2023 | https://conductscience.org/library/papers/37736880 | PubMed |
| 37142668 | Antiproliferative effects of mitochondria-targeted N-acetylcysteine and analogs in cancer cells. | Sci Rep | 2023 | https://conductscience.org/library/papers/37142668 | PubMed |
| 35756631 | Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities. | Front Oncol | 2022 | https://conductscience.org/library/papers/35756631 | PubMed |
| 35332210 | Combining PEGylated mito-atovaquone with MCT and Krebs cycle redox inhibitors as a potential strategy to abrogate tumor cell proliferation. | Sci Rep | 2022 | https://conductscience.org/library/papers/35332210 | PubMed |
| 34976949 | Targeting Mitochondrial Metabolism and RNA Polymerase POLRMT to Overcome Multidrug Resistance in Cancer. | Front Chem | 2021 | https://conductscience.org/library/papers/34976949 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33398166
GET https://conductscience.org/api/papers/v1/33398166/authors